Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …
This guideline provides recommendations for the use of PET imaging in gliomas. The review
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …
Value of 11C-methionine PET in imaging brain tumours and metastases
AWJM Glaudemans, RH Enting… - European journal of …, 2013 - Springer
Abstract 11 C-methionine (MET) is the most popular amino acid tracer used in PET imaging
of brain tumours. Because of its characteristics, MET PET provides a high detection rate of …
of brain tumours. Because of its characteristics, MET PET provides a high detection rate of …
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
Imaging techniques are important for accurate diagnosis and follow-up of patients with
gliomas. T1-weighted MRI, with or without gadolinium, is the gold standard method …
gliomas. T1-weighted MRI, with or without gadolinium, is the gold standard method …
Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies
N Verma, MC Cowperthwaite, MG Burnett… - Neuro …, 2013 - academic.oup.com
Differentiating treatment-induced necrosis from tumor recurrence is a central challenge in
neuro-oncology. These 2 very different outcomes after brain tumor treatment often appear …
neuro-oncology. These 2 very different outcomes after brain tumor treatment often appear …
Molecular imaging of gliomas with PET: opportunities and limitations
Neuroimaging enables the noninvasive evaluation of glioma and is considered to be one of
the key factors for individualized therapy and patient management, since accurate diagnosis …
the key factors for individualized therapy and patient management, since accurate diagnosis …
The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma
N Galldiks, G Stoffels, C Filss, M Rapp, T Blau… - Neuro …, 2015 - academic.oup.com
Background We evaluated the diagnostic value of static and dynamic O-(2-[18F] fluoroethyl)-
l-tyrosine (18F-FET) PET parameters in patients with progressive or recurrent glioma …
l-tyrosine (18F-FET) PET parameters in patients with progressive or recurrent glioma …
FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading
G Pöpperl, FW Kreth, JH Mehrkens, J Herms… - European journal of …, 2007 - Springer
Purpose Treatment and prognosis of gliomas depend on their histological tumour grade.
The aim of the study was to evaluate the potential of [18 F] fluoroethyltyrosine (FET) PET for …
The aim of the study was to evaluate the potential of [18 F] fluoroethyltyrosine (FET) PET for …
Tumor cell metabolism imaging
C Plathow, WA Weber - Journal of Nuclear Medicine, 2008 - jnm.snmjournals.org
Molecular imaging of tumor metabolism has gained considerable interest, since preclinical
studies have indicated a close relationship between the activation of various oncogenes and …
studies have indicated a close relationship between the activation of various oncogenes and …
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy–detecting illusive disease, defining response
Glioblastoma, the most common malignant primary brain tumor in adults is a devastating
diagnosis with an average survival of 14–16 months using the current standard of care …
diagnosis with an average survival of 14–16 months using the current standard of care …
Brain tumors
This review addresses the specific contributions of nuclear medicine techniques, and
especially positron emission tomography (PET), for diagnosis and management of brain …
especially positron emission tomography (PET), for diagnosis and management of brain …